Prestige Consumer Healthcare Inc.
corporate_fare Company Profile
Prestige Consumer Healthcare Inc. (NYSE:PBH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 18 items for PBH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-06, rated 8/10. Across its 18 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for PBH spans 10-Q, 8-K, 8-K/A, 10-K.
Recent high-impact activity:
- Prestige Consumer Healthcare Q1 FY2027: Revenue Climbs 6.5% on Breathe Right, but Integration Costs Weigh on Margins
- Prestige Consumer Healthcare Tops Q1 Estimates and Lifts FY27 Guidance, Fueled by Acquisitions
- Prestige Consumer Healthcare Raises FY27 Outlook to Include Acquisitions
- Prestige Consumer Healthcare Locks In $400M Senior Notes at 6.250%
- Prestige Consumer Healthcare Finalizes LaCorium Acquisition, Prices $400M Senior Notes at 6.25%
Financial Snapshot
Short Interest & Short Volume
9.45 days to coverFINRA reported short interest of 4,794,058 shares in PBH as of the September 15, 2026 settlement, a 4.6% increase from the prior period — about 9.4 days to cover at its recent average daily volume. On October 2, 2026, 72.3% of PBH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.